Illustrative Clinical AI Translation Report

01

Model and example version

Illustrative longitudinal documentation prototype, checkpoint DOC-DEMO-0.8. Example record SYN-TR-ILL-001. Both identifiers are fictional and are shown only to illustrate versioned reporting.

02

Declared intended use

Draft a clinician-reviewable longitudinal summary from structured and narrative outpatient chart context. The output requires human review and is not a diagnosis, clinical recommendation, or patient-specific prediction.

03

Translation objective

Determine whether the prototype can represent a renal-function trend distributed across visits without inventing a diagnosis, causal explanation, or management recommendation.

04

Evaluation question

When renal-function evidence is split across visits or the latest result is documented late, does the model acknowledge the available trend and the missing context while staying faithful to the record?

05

Scenario family

Synthetic longitudinal outpatient records vary the timing, completeness, and wording of renal-function evidence while preserving the underlying clinical state.

• stable and changing renal-function patterns
• current, delayed, and missing laboratory evidence
• sparse and dense visit documentation
• controlled wording and note-order variants

06

Measured blind spot

Within this fictional workflow, the predefined case family exposes an omission pattern: the prototype underweights the longitudinal trend when earlier values and a delayed result are separated across the chart.

07

Why the blind spot matters

A summary that omits available longitudinal context may be less useful for downstream human review. This example does not claim that the behavior caused patient harm or establishes a safety result.

08

Whether the gap appears correctable

Potentially correctable with targeted training data, subject to a reproducible adaptation path and defensible labels. The same pattern could instead require revised labeling, a workflow change, or a narrower intended use.

09

Proposed synthetic hardening cohort

Build a frozen cohort of checked synthetic clinical worlds around the measured evidence condition. Keep hardening examples separate from fixed diagnostic and regression cases.

• balanced trend and no-trend examples
• delayed-result and missing-context variants
• controlled note-order and wording changes
• artifact checks, cohort manifest, and use boundary

10

Proposed model or workflow intervention

Use a customer-run, Synset-supported, or approved-partner adaptation workflow agreed before evaluation. Freeze the cohort, intervention settings, and resulting candidate checkpoint before the final holdout is accessed.

11

Held-out real-data evaluation plan

Compare the frozen original and candidate checkpoints on locked, customer-controlled real data that was not used to select or tune the intervention.

• prespecify the primary task criterion before the run
• prespecify no-regression, subgroup, and calibration checks where supported
• record model, data, rubric, and protocol versions
• do not iteratively optimize against the final holdout result

12

Regression artifact to preserve

Retain the renal-trend scenario family, model-facing evidence, expected-behavior rubric, and frozen scoring rule as a versioned suite for future model and workflow updates.

13

Recommended next decision

Proceed only if the model has a reproducible adaptation path, the target behavior can be labeled defensibly, and a locked real evaluation set can be used. Otherwise collect new real evidence, revise the workflow, narrow the intended use, or stop.

14

Limitations and claim boundary

This report is a fictional product illustration. It is not customer evidence, clinical validation, regulatory advice, deployment authorization, a synthetic-control-arm result, or proof that synthetic data improves real-world model performance.